(Q48029126)
Statements
Phase I safety and immunogenicity testing of clinical lots of the synthetic Plasmodium falciparum vaccine SPf66 produced under good manufacturing procedure conditions in the United States (English)
W R Ballou
D M Gordon
P E Duffy
J A Lyon
J S Williams
D Scheumann
L Farley
D Stacey
J D Haynes